Paper655118
The treatment of low-renin ("primary") hyperaldosteronism.
Ferriss JB and 8 others. Am Heart J, 1978. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. The treatment of low-renin ("primary") hyperaldosteronism. Papers, record 655118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/655118
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperaldosteronism | Major topic |
| Adenoma | |
| Adrenal Cortex Neoplasms | |
| Adrenalectomy | |
| Amiloride | |
| Blood Pressure | |
| Dexamethasone | |
| Female | |
| Humans | |
| Male | |
| Potassium | |
| Renin | |
| Spironolactone |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23551726 | Hormones other than aldosterone may contribute to hypertension in 3 different subtypes of primary aldosteronism. | J Clin Hypertens (Greenwich) | 2013 | https://conductscience.org/library/papers/23551726 | PubMed |
| 22496413 | ENaC inhibition stimulates Cl- secretion in the mouse cortical collecting duct through an NKCC1-dependent mechanism. | Am J Physiol Renal Physiol | 2012 | https://conductscience.org/library/papers/22496413 | PubMed |
| 21305359 | Treatment of primary aldosteronism: Where are we now? | Rev Endocr Metab Disord | 2011 | https://conductscience.org/library/papers/21305359 | PubMed |
| 16823578 | [Modern pharmacological aspects of hyperaldosteronism therapy]. | Internist (Berl) | 2006 | https://conductscience.org/library/papers/16823578 | PubMed |
| 12080439 | Aldosterone excess and essential hypertension. | J Hum Hypertens | 2002 | https://conductscience.org/library/papers/12080439 | PubMed |
| 7711431 | Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands. | Clin Investig | 1994 | https://conductscience.org/library/papers/7711431 | PubMed |
| 6790017 | Sodium and potassium in essential hypertension. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6790017 | PubMed |
| 3889485 | Captopril before and after spironolactone therapy in primary aldosteronism. Pathogenetic and therapeutical aspects. | Klin Wochenschr | 1985 | https://conductscience.org/library/papers/3889485 | PubMed |
| 3765616 | Malignant hypertension and asymmetric septal hypertrophy in a 43-year-old black man. | West J Med | 1986 | https://conductscience.org/library/papers/3765616 | PubMed |
| 2368435 | Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma. | World J Surg | 1990 | https://conductscience.org/library/papers/2368435 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/655118
GET https://conductscience.org/api/papers/v1/655118/authors